Your browser doesn't support javascript.
loading
Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.
Potocnjak, Ines; Trbusic, Matias; Teresak, Sanda Dokoza; Radulovic, Bojana; Pregartner, Gudrun; Berghold, Andrea; Tiran, Beate; Marsche, Gunther; Degoricija, Vesna; Frank, Sasa.
Afiliación
  • Potocnjak I; University Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
  • Trbusic M; University Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
  • Teresak SD; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Radulovic B; University Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia.
  • Pregartner G; University Hospital Centre Zagreb, Zagreb, Croatia.
  • Berghold A; Institute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Graz, Austria.
  • Tiran B; Institute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Graz, Austria.
  • Marsche G; Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Degoricija V; Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
  • Frank S; University Hospital Centre Sisters of Charity, Department of Medicine, Zagreb, Croatia. vdegoric@mef.hr.
Sci Rep ; 7(1): 1165, 2017 04 26.
Article en En | MEDLINE | ID: mdl-28446761
ABSTRACT
We hypothesised that the established association of endothelial lipase (EL) plasma levels with atherogenic lipid profile is altered in acute heart failure (AHF) and additionally affected by overlapping metabolic syndrome (MetS). We examined the association of EL plasma levels and lipid/lipoprotein plasma levels in AHF patients without and with overlapping MetS. The study was performed as a single-centre, observational study on 152 AHF patients, out of which 85 had overlapping MetS. In the no-MetS group, EL plasma levels were significantly positively correlated with plasma levels of atherogenic lipids/lipoproteins, including total cholesterol, low-density lipoprotein (LDL)-cholesterol, total LDL particles and triglycerides, but also with plasma levels of antiatherogenic high-density lipoprotein (HDL)-cholesterol, total HDL particles and small HDL particles. In the MetS group, EL plasma levels were positively correlated with triglyceride and small LDL-particle levels, and significantly negatively correlated with plasma levels of large HDL particles as well as with LDL- and HDL-particle size, respectively. EL- and lipid/lipoprotein- plasma levels were different in the no-MetS patients, compared to MetS patients. The association of EL with atherogenic lipid profile is altered in AHF and additionally modified by MetS, which strongly modulates EL- and lipid/lipoprotein-plasma levels in AHF.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Plasma / Síndrome Metabólico / Insuficiencia Cardíaca / Lipasa / Lípidos / Lipoproteínas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Croacia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Plasma / Síndrome Metabólico / Insuficiencia Cardíaca / Lipasa / Lípidos / Lipoproteínas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Croacia